BTG Pactual Global Asset Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

BTG Pactual Global Asset Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-11,400	Closed	-$2.47M	–	89
2021 Q1	$2.47M	Buy	+11,400	New	+$2.14M	0.67%	45

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $983M AUM 34.23% 1-Year Est. Return

BTG Pactual Global Asset Management's GWPH Position: Q2 2021 in Review

BTG Pactual Global Asset Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 11,400 shares — an estimated $2.47M sold.

BTG Pactual Global Asset Management first reported a position in GWPH in Q1 2021 and held it in 1 quarter. The position peaked at $2.47M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

BTG Pactual Global Asset Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
BTG Pactual Global Asset Management sold 11,400 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $2.47M.
BTG Pactual Global Asset Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2021 and held it in 1 quarter.
BTG Pactual Global Asset Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $2.47M in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on BTG Pactual Global Asset Management's 13F filing for Q2 2021, filed 13 Aug 2021.